Finalist – Emerging Medical Innovation Valuation Competition
Hibernicor’s Asporto heart transplant device has been selected as a finalist in the Emerging Medical Innovation Valuation Competition, as part of the Design of Medical Devices Conference at the University of Minnesota. Hibernicor was one of five finalists among 24 submissions from 10 states and four countries.